Human Microbiome Human Microbiome Market

Human Microbiome Market

Human Microbiome Market - By Product (Probiotics, Prebiotics, Medical Foods, and Supplements), By Application (Therapeutics And Diagnostics) And By Disease Type (Obesity, Diabetes, Autoimmune Disorder, Metabolic & Gastrointestinal Disorders, and Cancer): Global Industry Perspective, Comprehensive Analysis And Forecast, 2021 – 2028

Published Date: 30-Nov-2021 Category: Healthcare Report Format : PDF Pages: 157 Report Code: ZMR-1473 Status : Published

Global human microbiome market expected to generate revenue of around USD 1,365.49 million by the end of 2024, growing at a CAGR of around 9.40% between 2018 and 2024. The human microbiome is the genetic material of microbes such as bacteria, protozoa, viruses, and fungi which are present in or on a human body.

The global Human Microbiome Market accrued earnings worth approximately 750 (USD Million) in 2020 and is predicted to gain revenue of about 1,597 (USD Million) by 2028, is set to record a CAGR of nearly 9.40% over the period from 2021 to 2028. The report offers assessment and analysis of the Human Microbiome Market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Million).

Global Human Microbiome Market: Outlook

Human microbiome consists of viruses, archaea, eukaryotes, and bacteria residing inside as well as outside of human body at various sites. Furthermore, human microbiome is referred as genomic content of microorganisms that inhabits a particular location in human body system such as skin, gastrointestinal tract, mammary gland, respiratory tract, mucosa, and urogenital tract. Moreover, these microbes affect human physiology contributing towards improvement as well as impairment of both immune & metabolic activities during good health & disorders. Rapid development of sequence and analytical methods are increasing our ability in understanding human microbiome working and its constituents.  Moreover, human microbiota comprises of 10 to 100 trillion symbiotic microbial tissue cells that are harbored by each individual and human microbiome comprises of genes of these microbial tissue cells harbor.

Global Human Microbiome Market

For the record, studies of diverse human microbiome commenced with Antonie Van Leewenhoek. Reportedly, he in 1680s compared his own fecal with his oral microbiota and found huge differences in microbes of both. Moreover, he also found profound differences between samples of two habitats taken from large number of population. Moreover, in modern times, not only these differences are measured by using various techniques, but some strong powerful methods such as molecular techniques are developed in understanding the differences existing between two habitats as well as gain insights into how one can impact transformation from one state to other state.  

Human Microbiome Market: Growth Factors

Breakthroughs in sequencing techniques & understanding of microbiome are projected to provide insights into microbiota and thereupon decide on personalized medicine treatment for each individual based on the extracted microbiota information. This is predicted to create new growth opportunities for human microbiome market in near future. Furthermore, microbiome ventures are launched across globe with an aim of knowing roles played by symbionts as well as their impact on health of human beings, thereby driving industry trends. Understanding human microbiome helps in garnering information about presence of cancer tissues as well as identifying inflammatory bowel disease causing viruses and allergy causing microbes.

Furthermore, human microbiome plays a key role in development & maintenance of human body. Moreover, these microorganisms hold a key to development of immune system & hosts nutrition, homeostasis maintenance, and colonization resistance as well as immune regulation in young children and neonates. Major role played by microbiome in human health development will prompt growth of human microbiome market over forecasting timeframe. Furthermore, human microbiome is a major source of genetic diversity, disease modifier, a key immunity component, and functional entity influencing body metabolism and modulating medicine interactions. Moreover, examination of human microbiome has been highly influenced due to breakthroughs taking place in genome technologies. Additionally, developments witnessed in biotechnology domain and particularly in genome field have helped researchers to delve deep into human microbiome studies and gain comprehensive understanding about its findings.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Regional Insights

North America To Contribute Majorly Towards Human Microbione Market Size By 2028

Growth of regional market over forecast timespan is subject to amplicon-based surveys carried on human microbial communities and microbial genome sequencing & whole-genome shotgun metagenomic sequencing activities in various reputed biotech firms based in the U.S. In addition to this, presence of giant biotech players in the countries such as Canada and the U.S. will contribute lucratively towards regional market size. Growing focus on human microbiome drug development and launching of new kinds of antibiotics for treating disease after studying human microbiome in the U.S. labs will steer growth of human microbiome market in sub-continent.

Competitive Insights

Key players favorably impacting growth of human microbione market and profiled in study are Rebiotix, Inc., Osel, Inc., OBiome LLC, Vedanta Biosciences, Second Genome, Seres Therapeutics, Enterome Biosciences, Metabiomics Corp., uBiome, Inc., and Synthetic Biologics, Inc. 

The global Human Microbiome Market is segmented as follows:

By Product

By Disease Type

  • Obesity
  • Diabetes
  • Autoimmune Disorder
  • Metabolic & Gastrointestinal Disorders
  • Cancer

By Application

  • Therapeutics
  • Diagnostics

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

Free Analysis

FrequentlyAsked Questions

Breakthroughs in sequencing techniques & understanding of microbiome are projected to provide insights into microbiota and thereupon decide on personalized medicine treatment for each individual based on the extracted microbiota information. This is predicted to create new growth opportunities for human microbiome market in near future. Furthermore, microbiome ventures are launched across globe with an aim of knowing roles played by symbionts as well as their impact on health of human beings, thereby driving industry trends. Understanding human microbiome helps in garnering information about presence of cancer tissues as well as identifying inflammatory bowel disease causing viruses and allergy causing microbes.

 Furthermore, human microbiome plays a key role in development & maintenance of human body. Moreover, these microorganisms hold a key to development of immune system & hosts nutrition, homeostasis maintenance, and colonization resistance as well as immune regulation in young children and neonates. Major role played by microbiome in human health development will prompt growth of human microbiome market over forecasting timeframe.   

According to Zion market research report, the global Human Microbiome Market accrued earnings worth approximately 750 (USD Million) in 2020 and is predicted to gain revenue of about 1,597 (USD Million) by 2028, is set to record a CAGR of nearly 9.40% over the period from 2021 to 2028.

North America will contribute lucratively towards the global market earnings over the projected timeline. The regional market surge is subject to amplicon-based surveys carried on human microbial communities and microbial genome sequencing & whole-genome shotgun metagenomic sequencing activities in various reputed biotech firms based in the U.S. In addition to this, presence of giant biotech players in the countries such as Canada and the U.S. will contribute lucratively towards regional market size. Growing focus on human microbiome drug development and launching of new kinds of antibiotics for treating disease after studying human microbiome in the U.S. labs will steer growth of human microbiome market in sub-continent.

The key market participants include Rebiotix, Inc., Osel, Inc., OBiome LLC, Vedanta Biosciences, Second Genome, Seres Therapeutics, Enterome Biosciences, Metabiomics Corp., uBiome, Inc., and Synthetic Biologics, Inc. 

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed